Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1787297 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $4.51 · Day −0.22% · Mkt cap $15M · 1Y −34.9% · Off 52W high −77.5% · Vol (1Y) 112.1% Price2023-08-21 → 2026-08-19 PASG close: $15.0 on 2023-08-21 to $4.5 on 2026-08-19. Split-adj closes · 240 of 1,622 · price returnⓘ At a glance | Short interest4.8% of sh out | | Days to cover4.5d | | 13F net flow (QoQ)+3.61% | | Top-10 13F concentration90.9% | | Next report (est.)2026-11-08 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$36.1M | | ROE−113.8% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−61.8% | | 1Y−34.9% | | 3Y−69.9% | | 5Y−97.9% | | Since incept. (ann.)−50.8% |
Total return · from 2020-02-28ⓘ Risk | Ann. volatility (1Y)112.1% | | Ann. volatility (3Y)116.1% | | Sharpe (1Y)0.16 | | Sharpe (3Y)0.20 | | Max drawdown (1Y)−79.4% | | Max drawdown (3Y)−88.2% | | Beta (3Y vs SPY)2.66 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Lynx1 Capital Management LP | 623,704 | $5M | 19.44% | +0.0% | | Vestal Point Capital, LP | 305,000 | $2M | 9.51% | +0.0% | | RENAISSANCE TECHNOLOGIES LLC | 133,612 | $1M | 4.17% | +22.5% | | Eversept Partners, LP | 131,581 | $1M | 4.10% | +4.2% | | VANGUARD CAPITAL MANAGEMENT LLC | 113,964 | $894,617 | 3.55% | new | | Yiheng Capital Management, L.P. | 86,097 | $675,861 | 2.68% | +151.0% | | Ikarian Capital, LLC | 68,124 | $534,773 | 2.12% | new | | Erste Asset Management GmbH | 85,262 | $526,919 | 2.66% | +0.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-10 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-10 | −$2.44 | — | — | — | | 2026-03-31 | 2026-05-12 | −$2.36 | — | — | — | | 2025-09-30 | 2025-11-10 | −$2.44 | — | — | — | | 2025-06-30 | 2025-08-12 | −$2.96 | — | — | — |
As-reported XBRL · next 2026-11-08 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
